The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis
Open accessAbstract
Fractalkine, a chemokine expressed by inflamed endothelium, induces leukocyte adhesion and migration via the receptor CX3CR1, and the CX3CR1 polymorphism V249I affects receptor expression and function. Here we show that this polymorphism is an independent risk factor for atherosclerotic coronary artery disease (CAD). Genotyping of the CX3CR1-V249I polymorphism was performed in a cohort of 339 white individuals who underwent cardiac catheterization (n=197 with and n=142 without CAD, respectively). In 203 patients, intracoronary acetylcholine 15 μg/min) and sodium nitroprusside (20 μg/min) were administered to test endothelium-dependent and -independent coronary vascular function, respectively. Change in coronary vascular resistance (ΔCVR) was measured as an index of microvascular dilation. An association was observed between presence of the CX3CR1 I249 allele and reduced prevalence of CAD, independent of established CAD risk factors (odds ratio=0.54 [95% confidence interval, 0.30 to 0.96],P=0.03). Angiographic severity of CAD was also lower in these subjects (P=0.01). Furthermore, endothelium-dependent vasodilation was greater in these individuals compared with individuals homozygous for the CX3CR1-V249 allele (ΔCVR during acetylcholine = −46±3% versus −36±3%, respectively,P=0.02), whereas ΔCVR with sodium nitroprusside was similar in both groups (−55±2% versus −53±2%,P=0.45). The association between CX3CR1 genotype and endothelial function was independent of established risk factors and presence of CAD by multivariate analysis (P=0.02). Thus, the CX3CR1 I249 allele is associated with decreased risk of CAD and improved endothelium-dependent vasodilation. This suggests that CX3CR1 may be involved in the pathogenesis of CAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,585
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
Suwaidi, J. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,043
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Self-citationGu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,445
Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins
Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B., & de Faire, U. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301503 · Cited by 1,255
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
Vita, J. A., Treasure, C. B., Nabel, E. G., McLenachan, J. M., Fish, R. D., Yeung, A. C., Vekshtein, V. I., Selwyn, A. P., & Ganz, P. (1990) · Circulation · doi:10.1161/01.cir.81.2.491 · Cited by 1,173
Weiss, E. J., Bray, P. F., Tayback, M., Schulman, S. P., Kickler, T. S., Becker, L. C., Weiss, J. L., Gerstenblith, G., & Goldschmidt-Clermont, P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341703 · Cited by 689
Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1413 · Cited by 679
Fichtlscherer, S., Rosenberger, G., Walter, D. H., Breuer, S., Dimmeler, S., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.102.9.1000 · Cited by 665
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
Pan, Y., Lloyd, C., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J.-A., Vath, J., Gosselin, M., Ma, J., Dussault, B., et al. (1997) · Nature · doi:10.1038/42491 · Cited by 644
Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans
Hingorani, A. D., Cross, J., Kharbanda, R. K., Mullen, M. J., Bhagat, K., Taylor, M., Donald, A. E., Palacios, M., Griffin, G. E., Deanfield, J. E., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.994 · Cited by 605
Infection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Quyyumi, A. A., Dakak, N., Andrews, N. P., Husain, S., Arora, S., Gilligan, D. M., Panza, J. A., & Cannon, R. O. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117852 · Cited by 444
Self-citationZimmerman, P. A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401665 · Cited by 416
Self-citationThe genetic basis of common diseases.
King, R. A., Rotter, J. I., & Motulsky, A. G. (2002) · Cited by 409
Endothelial function in health and disease: new insights into the genesis of cardiovascular disease
Quyyumi, A. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00209-5 · Cited by 406
Self-citationPolymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
Moatti, D. (2001) · Blood · doi:10.1182/blood.v97.7.1925 · Cited by 349
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
C. Dawson, T., A. Kuziel, W., A. Osahar, T., & Maeda, N. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00318-9 · Cited by 339
Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., ALT, F., Groups, I. S., Delfraissy, J.-F., Group, S. S., et al. (2000) · Science · doi:10.1126/science.287.5461.2274 · Cited by 323
Self-citationContribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart
Quyyumi, A. A., Dakak, N., Andrews, N. P., Gilligan, D. M., Panza, J. A., & Cannon, R. O. (1995) · Circulation · doi:10.1161/01.cir.92.3.320 · Cited by 321
Self-citationShimasaki, Y., Yasue, H., Yoshimura, M., Nakayama, M., Kugiyama, K., Ogawa, H., Harada, E., Masuda, T., Koyama, W., Saito, Y., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00167-3 · Cited by 305
嶋崎, 幸. (1999) · Medical Entomology and Zoology · doi:10.11501/3166056 · Cited by 292
Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction
Haskell, C. A., Cleary, M. D., & Charo, I. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10053 · Cited by 235
Goda, S., Imai, T., Yoshie, O., Yoneda, O., Inoue, H., Nagano, Y., Okazaki, T., Imai, H., Bloom, E. T., Domae, N., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4313 · Cited by 224
Zhu, J., Quyyumi, A. A., Rott, D., Csako, G., Wu, H., Halcox, J., & Epstein, S. E. (2001) · Circulation · doi:10.1161/01.cir.103.8.1071 · Cited by 213
Self-citationDetmers, P. A., Hernandez, M., Mudgett, J., Hassing, H., Burton, C., Mundt, S., Chun, S., Fletcher, D., Card, D. J., Lisnock, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3430 · Cited by 207
Fractalkine-Mediated Endothelial Cell Injury by NK Cells
Yoneda, O., Imai, T., Goda, S., Inoue, H., Yamauchi, A., Okazaki, T., Imai, H., Yoshie, O., Bloom, E. T., Domae, N., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4055 · Cited by 192
Garcia, G. E., Xia, Y., Chen, S., Wang, Y., Ye, R. D., Harrison, J. K., Bacon, K. B., Zerwes, H.-G., & Feng, L. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.577 · Cited by 179
Novel Risk Factors for Atherosclerosis
Kullo, I. J., Gau, G. T., & Tajik, A. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.369 · Cited by 161
Nitric Oxide Activity in the Atherosclerotic Human Coronary Circulation
Quyyumi, A. A., Dakak, N., Mulcahy, D., Andrews, N. P., Husain, S., Panza, J. A., & Cannon, R. O. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00472-x · Cited by 150
Self-citationContribution of Nitric Oxide to Reactive Hyperemia
Dakak, N., Husain, S., Mulcahy, D., Andrews, N. P., Panza, J. A., Waclawiw, M. A., Schenke, W. H., & Quyyumi, A. A. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.9 · Cited by 147
Self-citationCoronary Vascular Nitric Oxide Activity in Hypertension and Hypercholesterolemia
Quyyumi, A. A., Mulcahy, D., Andrews, N. P., Husain, S., Panza, J. A., & Cannon, R. O. (1997) · Circulation · doi:10.1161/01.cir.95.1.104 · Cited by 144
Self-citationPrasad, A., Narayanan, S. N., Husain, S., Padder, F. A., Waclawiw, M. A., Epstein, N., & Quyyumi, A. A. (2000) · Circulation · doi:10.1161/01.cir.102.1.35 · Cited by 134
Self-citationPeroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease
Wang, X. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00256-4 · Cited by 127
Relation of inflammation to vascular function in patients with coronary heart disease
Sinisalo, J. P., Paronen, J., Mattila, K. J., Syrjälä, M. T., Alfthan, G., Palosuo, T., Nieminen, M. S., & Vaarala, O. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00333-0 · Cited by 126
O’Keefe, J. H., Wetzel, M., Moe, R. M., Brosnahan, K., & Lavie, C. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01044-5 · Cited by 119
Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart
Harrison, J. K., Jiang, Y. J., Wees, E. A., Salafranca, M. N., Liang, H., Feng, L., & Belardinelli, L. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.6.937 · Cited by 89
Genetic Polymorphism in CX 3 CR1 and Risk of HIV Disease
McDermott, D. H., Colla, J. S., Kleeberger, C. A., Plankey, M. W., Rosenberg, P. S., Smith, E. D., Zimmerman, P. A., Combadière, C., Leitman, S. F., Kaslow, R. A., et al. (2000) · Science · doi:10.1126/science.290.5499.2031a · Cited by 89
Self-citationChemokines, leukocytes, and atherosclerosis
Gerszten, R. E., Mach, F., Sauty, A., Rosenzweig, A., & Luster, A. D. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.108154 · Cited by 81
Orth, M., Weng, W., Funke, H., Steinmetz, A., Assmann, G., Nauck, M., Dierkes, J., Ambrosch, A., Weisgraber, K. H., Mahley, R. W., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1306 · Cited by 42
Participation of Innate and Acquired Immunity in Atherosclerosis
Curtiss, L. K., Kubo, N., Schiller, N. K., & Boisvert, W. A. (2000) · Immunologic Research · doi:10.1385/ir:21:2-3:167 · Cited by 28
Does Chlamydia pneumoniae Cause Atherosclerosis?
Grayston, J. T. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.9.930 · Cited by 23
Cited by
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
“, and an allele of CX3CR1 that exerts impaired adhesive function and blunted signaling is associated with dominantly inherited, reduced risk for atherosclerotic end point”
BackgroundBachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationMechanisms of disease: pulmonary arterial hypertension
Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R., & Grimminger, F. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.87 · Cited by 800
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3775 · Cited by 713
Metadata
- Authors
- McDermott, D. H., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., & Murphy, P. M.
- Venue
- Circulation Research
- Published
- 2001-08-31
- Volume
- 89
- Issue
- 5
- Pages
- 401-407
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2109997080
- Cited by
- 256
- References
- 50
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.